Cellosaurus logo
expasy logo

Cellosaurus Y-MESO-14/hPDPN (CVCL_D2U3)

[Text version]
Cell line name Y-MESO-14/hPDPN
Accession CVCL_D2U3
Resource Identification Initiative To cite this cell line use: Y-MESO-14/hPDPN (RRID:CVCL_D2U3)
Comments Population: Japanese.
Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29602; PDPN.
Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
Sequence variations
  • Gene deletion; HGNC; HGNC:6515; LATS2; Zygosity=Homozygous (from parent cell line).
  • Mutation; HGNC; HGNC:950; BAP1; Simple; p.Lys116Glyfs*5 (c.349_359del11); Zygosity=Unspecified (from parent cell line).
  • Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000457921; Zygosity=Unspecified (from parent cell line).
Disease Pleural biphasic mesothelioma (NCIt: C45665)
Pleural mesothelioma (ORDO: Orphanet_50251)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_5179 (Y-MESO-14)
Sex of cell Male
Age at sampling 54Y
Category Cancer cell line
Publications

PubMed=25080943; DOI=10.1038/srep05924; PMCID=PMC4118152
Kato Y., Kaneko M.K.
A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin.
Sci. Rep. 4:5924-5924(2014)

PubMed=28387591; DOI=10.1089/mab.2017.0001
Yamada S., Ogasawara S., Kaneko M.K., Kato Y.
LpMab-23: a cancer-specific monoclonal antibody against human podoplanin.
Monoclon. Antib. Immunodiagn. Immunother. 36:72-76(2017)

Cross-references
Encyclopedic resources Wikidata; Q127384730
Entry history
Entry creation30-Jan-2024
Last entry update19-Dec-2024
Version number3